Lates News

Reviva Pharmaceuticals (RVPH.US): The revenue in the first quarter of 2025 was 0 US dollars, unchanged from the previous period. Earnings per share were -0.13 US dollars, compared to -0.25 US dollars in the previous period. The expected value was -0.19 US dollars.